doi: 10.1053/jhep.2002.34939 110 ChenBBaiYTongFYanJZhangRZhongYet al
Fujian Shengdi Pharmaceutical: HRS9531 (Subsidiary of Jiangsu Hengrui Pharmaceutical) [59] [59] In a phase 1 study evaluating an oral GLP1R/GIP dual agonist, participants received subcutaneous injections of 8.1mg
10.1016/j.physbeh.2022.113843 Physiol Behav
From a manufacturing standpoint, this level of infrastructure indicates that the company is built to handle both high-volume orders and diverse product categories
However, some of the more recent ones, like liraglutide (Larsen et al., 2017), semaglutide, and, in particular, tirzepatide (trade name Mounjaro) have shown good research data suggesting that they can produce a substantial amount of weight loss in addition to correcting things like glucose tolerance and also assisting with decreasing lipid abnormalities (Flory & Lipska, 2019)